Global Hyoscine-N-Butyl Bromide Market Insights, Experiments, Evolution, Ferment

Posted by Deeksha on February 18th, 2019

This research report titled “Global Hyoscine-N-Butyl Bromide Market” Insights, Forecast to 2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Hyoscine-N-Butyl Bromide Market during the period between 2019 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to enlighten the readers about the actual scenario prevailing in the Hyoscine-N-Butyl Bromide Market.

Get Sample Copy of This Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2093150

 Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.

It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms.

Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions. 
The production of Hyoscine-N-Butyl Bromideis increased from 6.3 MT in 2012 to 6.9 MT in 2016, at a CARG 2.54%. The manufacturers are Boehringer-Ingelheim, Linnea, Alchem International and Alkaloids.

Boehringer-Ingelheim is the world leader with 77.62% of market share in 2016. Boehringer-Ingelheim produces both Hyoscine-N-Butyl Bromideis API and Buscopan. They mainly sale Buscopan in market and the revenue of Buscopan is 236 EUR million and the revenue of Hyoscine-N-Butyl Bromideis API is 30.2 million USD in 2016.
Global Hyoscine-N-Butyl Bromide market size will increase to 63 Million US$ by 2025, from 40 Million US$ in 2018, at a CAGR of 5.9% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hyoscine-N-Butyl Bromide.

This report researches the worldwide Hyoscine-N-Butyl Bromide market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Hyoscine-N-Butyl Bromide breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Boehringer-Ingelheim
Linnea, Alchem International
Alkaloids

Hyoscine-N-Butyl Bromide Breakdown Data by Type
Boehringer-Ingelheim
Linnea
Alchem International
Alkaloids
Hyoscine-N-Butyl Bromide Breakdown Data by Application
Oral
Injection

Hyoscine-N-Butyl Bromide Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Hyoscine-N-Butyl Bromide Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa